In Vivo Gene Therapy of Ovarian Cancer by Adenovirus-Mediated Thymidine Kinase Gene Transduction and Ganciclovir Administration

By Tong X.-.W.   Block A.   Chen S.-.H.   Contant C.F.   Agoulnik I.   Blankenburg K.   Kaufman R.H.   Woo S.L.C.   Kieback D.G.  

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 175-179

Academic Press

Access to resources Recommend Favorite

Adenovirus-Mediated Thymidine Kinase Gene Therapy in Combination with Topotecan for Patients with Recurrent Ovarian Cancer: 2.5-Year Follow-Up

By Hasenburg A.   Tong X.-W.   Fischer P.D.   Rojas-Martinez A.   Nyberg-Hoffman C.   Kaplan A.L.   Kaufman R.H.   Ramzy I.   Aguilar-Cordova E.   Kieback D.G.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 549-554

Elsevier

Access to resources Recommend Favorite

Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro

By Freund C.T.F.   Tong X.-W.   Rowley D.   Engehausen D.   Frolov A.   Kieback D.G.   Lerner S.P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1435-1440

Spandidos Publications

Access to resources Recommend Favorite

Suicide Gene Therapy for Human Uterine Adenocarcinoma Cells Using Herpes Simplex Virus Thymidine Kinase

By Kunishige I.   Samejima Y.   Shiki Y.   Moriyama A.   Meruelo D.   Saji F.   Murata Y.  

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 16-25

Elsevier

Access to resources Recommend Favorite